Shields, N.; Colwill, M.; Raspa, V.; Twum-Danso, Y.; Poullis, A.; Patel, K.; Honap, S.
Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights. Biomedicines 2025, 13, 2655.
https://doi.org/10.3390/biomedicines13112655
AMA Style
Shields N, Colwill M, Raspa V, Twum-Danso Y, Poullis A, Patel K, Honap S.
Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights. Biomedicines. 2025; 13(11):2655.
https://doi.org/10.3390/biomedicines13112655
Chicago/Turabian Style
Shields, Natalie, Michael Colwill, Valentina Raspa, Yaw Twum-Danso, Andrew Poullis, Kamal Patel, and Sailish Honap.
2025. "Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights" Biomedicines 13, no. 11: 2655.
https://doi.org/10.3390/biomedicines13112655
APA Style
Shields, N., Colwill, M., Raspa, V., Twum-Danso, Y., Poullis, A., Patel, K., & Honap, S.
(2025). Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights. Biomedicines, 13(11), 2655.
https://doi.org/10.3390/biomedicines13112655
